| About us |
Injex-equidyne systems has a sizable inventory worth more than $1.5 million dollars at wholesale price, and a large production capacity for the disposable (comsumable) sterile ampules. We are currently selling the injex 30 needle free injector within the diabetes adn growth hormone (hgh) markets. The company's products have received marketing clearance from the FDA through the FDA 510 (k) notification process and was commercially introduced to the market in 1991.
|
|---|
| Industry Focus | Medical Supplies, Medical Equipment |
|---|
| Business Type | Manufacturer |
|---|
| Products/Services | Reusable, needle-free medication injector that uses spring technology to deliver medication subcutaneously (in the fatty tissue under the skin without the use of a needle) |
|---|
| Our Markets | North America |
|---|
| No. of Employees | 11 - 50 People |
|---|
